Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Correlogic Systems and JEOL Sign Research and Development Agreement

Abstract:
Joint Efforts to Advance Clinical Application of Mass Spectrometry

Correlogic Systems and JEOL Sign Research and Development Agreement

ROCKVILLE, MD | Posted on June 6th, 2007

Correlogic Systems, Inc. and JEOL, Ltd. today announced the signing of a research and development
agreement focused on further enhancing the performance of mass spectrometry
in a clinical setting. JEOL, headquartered in Tokyo, is a leading global
manufacturer of scientific instruments used for research and development in
the fields of nanotechnology, life sciences, optical communication,
forensics, and biotechnology. Correlogic, based in Rockville, Maryland has
pioneered the use of pattern recognition technologies for the development
of proteomic, metabolomic, and genomic based clinical prognostic and
clinical diagnostic tests. Correlogic and JEOL have collaborated for more
than a year under an informal agreement, and have made great strides in the
continuing validation of various mass spectrometer-based assays. Details of
the agreement were not released.

Over the past year, we have had a very close and productive research
collaboration with JEOL," said Peter J. Levine, President and CEO of
Correlogic Systems, Inc. "This agreement formalizes our link to one of the
world's leading mass spectrometer and NMR manufacturers."

####

About Correlogic Systems, Inc.
Correlogic Systems, Inc. has developed patented technology and processes with a wide variety of applications for biomarker discovery, disease detection, and new drug discovery. The technology's first application has been in the field of proteomics -- the study of human proteins. OvaCheck(R), a blood test for the early detection of ovarian cancer, is Correlogic's first diagnostic test using its patented "Hidden Patterns" approach. The test is undergoing the final stages of its extensive validation process. Correlogic has entered into marketing
agreements with Quest Diagnostics, Inc., and Laboratory Corporation of America for North America. Mitsui & Co., Ltd. and Quest Diagnostics are equity investors in Correlogic. Visit Correlogic at http://www.correlogic.com .

About JEOL, Ltd. JEOL is a world leader in electron optical equipment
and instrumentation for high-end scientific and industrial research and
development. Core product groups include electron microscopes (SEMs and
TEMs), instruments for the semiconductor industry (electron beam
lithography and a series of defect review and inspection tools), and
analytical instruments including mass spectrometers, NMRs and ESRs.
Headquartered in Tokyo, Japan, the company has offices throughout the
world.

Cautionary Statement: Certain statements contained in this release are
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements are based on management's
current expectations and are subject to uncertainty and changes in
circumstances. Actual results could differ materially due to, among other
things, operational and other difficulties associated with integrating
acquired business, general business conditions, competition among managed
care companies, rising health costs, trends in medical loss ratios, health
care reform, delay in receipt of regulatory and other approvals for pending
transactions and other regulatory issues.

For more information, please click here

Contacts:
Annette Fribourg
VP Government & Public Relations

301/795-1707

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

Graphene and quantum dots put in motion a CMOS-integrated camera that can see the invisible May 29th, 2017

Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017

Tools

Graphene and quantum dots put in motion a CMOS-integrated camera that can see the invisible May 29th, 2017

New metamaterial-enhanced MRI technique tested on humans May 26th, 2017

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

Nanomechanics, Inc. to Exhibit at the SEM Conference: Nanoindentation experts will attend and exhibit their instruments at the Conference and Exposition on Experimental and Applied Mechanics in Indianapolis May 25th, 2017

Alliances/Trade associations/Partnerships/Distributorships

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

BASF and Landa partner to create revolutionary pigments for automotive coatings: The alliance combines BASF innovations with Landa nano-pigment technology April 5th, 2017

Leti Announces EU/South Korean Project for Worlds First 5G-system Prototype: Coinciding with the 2018 Winter Games in PyeongChang, Korea, Prototype Will Be First Time State-of-the-art Terrestrial Wireless Communication Is Seamlessly Combined with Disruptive Satellite Communicati April 4th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Research partnerships

Graphene and quantum dots put in motion a CMOS-integrated camera that can see the invisible May 29th, 2017

Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017

Three-dimensional graphene: Experiment at BESSY II shows that optical properties are tuneable May 24th, 2017

Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project